Related references
Note: Only part of the references are listed.Dual Suppression of the Cyclin-Dependent Kinase Inhibitors CDKN2C and CDKN1A in Human Melanoma
Ahmad Jalili et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma
Julie A. Ellerhorst et al.
CLINICAL CANCER RESEARCH (2011)
Polo-Like Kinase 1 Is a Potential Therapeutic Target in Human Melanoma
Ahmad Jalili et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Topical Treatment of Basal Cell Carcinomas in Nevoid Basal Cell Carcinoma Syndrome with a Smoothened Inhibitor
Hans Skvara et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Resistance to BRAF Inhibition in Melanomas
David B. Solit et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
Jessie Villanueva et al.
CANCER CELL (2010)
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
Sonja J. Heidorn et al.
CELL (2010)
Smoothened as a new therapeutic target for human osteosarcoma
Masataka Hirotsu et al.
MOLECULAR CANCER (2010)
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
Georgia Hatzivassiliou et al.
NATURE (2010)
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Cory M. Johannessen et al.
NATURE (2010)
Melanomas acquire resistance toB-RAF(V600E) inhibition by RTK or N-RAS upregulation
Ramin Nazarian et al.
NATURE (2010)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Computational Prediction and Experimental Verification of New MAP Kinase Docking Sites and Substrates Including Gli Transcription Factors
Thomas C. Whisenant et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
Increasing Burden of Melanoma in the United States
Eleni Linos et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
1-Amino-4-benzylphthalazines as Orally Bioavailable Smoothened Antagonists with Antitumor Activity
Karen Miller-Moslin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Regulation of the Hedgehog Signaling by the Mitogen-Activated Protein Kinase Cascade in Gastric Cancer
Motoko Seto et al.
MOLECULAR CARCINOGENESIS (2009)
The mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor AZD6244 (ARRY-142886) induces growth arrest in melanoma cells and tumor regression when combined with docetaxel
Nikolas K. Haass et al.
CLINICAL CANCER RESEARCH (2008)
Epidemiology and clinical characteristics of ulcerative colitis in Chinese population: Experience from a single center in Hong Kong
Ka-Ho Lok et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Melanoma Genetics and Therapeutic Approaches in the 21st Century: Moving from the Benchside to the Bedside
Thomas L. Hocker et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases
Lei Xu et al.
MOLECULAR CANCER RESEARCH (2008)
Sonic hedgehog promotes proliferation and differentiation of adult muscle cells: Involvement of MAPK/EIK and PI3K/Akt pathways
Dafna Elia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells
Zhenyu Ji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Melanomas require HEDGEHOG-GLI signaling reaulated by interactions between GLI1 and the RAS-MEK/AKT pathways
Barbara Stecca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The hedgehog signaling pathway in cancer
Marie Evangelista et al.
CLINICAL CANCER RESEARCH (2006)
Malignant melanoma: genetics and therapeutics in the genomic era
Lynda Chin et al.
GENES & DEVELOPMENT (2006)
Mechanisms of disease - Melanoma
Arlo J. Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Lef1 is required for the transition of Wnt signaling from mesenchymal to epithelial cells in the mouse embryonic mammary gland
Kata Boras-Granic et al.
DEVELOPMENTAL BIOLOGY (2006)
Distinct sets of genetic alterations in melanoma
JA Curtin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Sonic hedgehog signaling regulates the expression of insulin-like growth factor binding protein-6 during fetal prostate development
RJ Lipinski et al.
DEVELOPMENTAL DYNAMICS (2005)
Hedgehog signaling and congenital malformations
E Nieuwenhuis et al.
CLINICAL GENETICS (2005)
Expression of the PTCH1 tumor suppressor gene is regulated by alternative promoters and a single functional Gli-binding site
M Ågren et al.
GENE (2004)
The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas
AR Hallahan et al.
CANCER RESEARCH (2004)
Microarray expression profiling in melanoma reveals a BRAF mutation signature
S Pavey et al.
ONCOGENE (2004)
Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria
XD Zhang et al.
ONCOGENE (2003)
Identification of a small molecule inhibitor of the hedgehog signaling pathway: Effects on basal cell carcinoma-like lesions
JA Williams et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened
JK Chen et al.
GENES & DEVELOPMENT (2002)
Small molecule modulation of Smoothened activity
JK Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Patched acts catalytically to suppress the activity of Smoothened
J Taipale et al.
NATURE (2002)
Augmented antitumour effects of combination therapy with TNP-470 and chemoimmunotherapy in mice
A Dabrowska-Iwanicka et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2002)
Mutations in SUFU predispose to medulloblastoma
MD Taylor et al.
NATURE GENETICS (2002)
Hedgehog signaling in animal development: paradigms and principles
PW Ingham et al.
GENES & DEVELOPMENT (2001)
A role of PDGFRα in basal cell carcinoma proliferation
JW Xie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Hedgehog induces opposite changes in turnover and subcellular localization of patched and smoothened
N Denef et al.
CELL (2000)
Genomic analysis of metastasis reveals an essential role for RhoC
EA Clark et al.
NATURE (2000)
Conditional inactivation of Fgf4 reveals complexity of signalling during limb bud development
X Sun et al.
NATURE GENETICS (2000)
Share Paper
